Benzinga | Feb 4, 2021 04:01PM EST

Arrowhead Pharmaceuticals Q1 EPS $(0.20) Misses $0.17 Estimate, Sales $21.30M Down From $29.45M YoY

Arrowhead Pharmaceuticals (NASDAQ:ARWR) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $0.17 by 217.65 percent. This is a 566.67 percent decrease over losses of $(0.03) per share from the same period last year. The company reported $21.30 million in sales this quarter. This is a 27.68 percent decrease over sales of $29.45 million the same period last year.